FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
An important email appeared in the inboxes of a small group of health care workers north of Boston as this
Read MoreSenate Minority Leader Mitch McConnell is “medically clear” to continue working, the attending physician for the U.S. Congress said one
Read MoreAugust 31, 2023 3 min read Source/Disclosures Disclosures: Korczak reports receiving grants from the Canada Institutes of Health Research and
Read MoreAugust 31, 2023 3 min read Source/Disclosures Disclosures: Mehta reports receiving a training grant from the Consortium of Eosinophilic Gastrointestinal
Read MoreA pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk,
Read MoreWere the flaxseed studies showing 20 pounds of weight loss just flukes? Canada now allows a health claim on the
Read MoreAugust 31, 2023 2 min read Source/Disclosures Published by: Disclosures: Tesch reports receiving funding support from the German Federal Ministry
Read MoreMontana’s legislature designated $3.7 million this spring to remove lead from school drinking-water supplies, then the state received $565,000 more
Read MoreAugust 30, 2023 2 min read Source/Disclosures Disclosures: Obara reports no relevant financial disclosures. Please see the study for all
Read MoreJames Romano trims flower while working in the CommCan processing facility in Medway, Massachusetts, Oct. 27, 2021. Erin Clark |
Read More